Mon–Fri 8–16
By Lotta Mitro
– I’m very happy to welcome Jenni Marko as the HR Director of our cancer center. Jenni Marko has extensive experience in the development of personnel competence and organisational culture. She is the right person for us in terms of experience and values, and she is an excellent fit for our team of professionals. As … Continued
By Lotta Mitro
Spanning more than 800 square metres, the extension was completed within the planned schedule. The extension was designed to provide more space, especially for early-stage diagnostic services, endoscopy services related to colorectal, oesophageal and stomach cancers and pathology functions. Also the facilities for mammography were renovated and a new separate room for gynecologist appointments was … Continued
By Lotta Mitro
Organised for the ninth time, the vote received more than 60 proposals, on the basis of which the panel of experts selected the Researcher, Research Nurse and Clinical Research Associate (CRA) of the Year. The Clinical Trials Forum honours research professionals each year in order to celebrate Finnish research expertise and to raise awareness and … Continued
By Lotta Mitro
The Finnish, privately owned Docrates Cancer Center has decided to invest in an expansion of its operations in Finland. The company’s revenue and clientele have continued to grow year after year, and Docrates now needs to expand in order to keep its customer promise: prompt and individualised cancer diagnostics and treatment. “The extension will have … Continued
By Lotta Mitro
Cancer treatment is becoming more and more personalised. In recent years, the greatest strides in personalised treatment have been made particularly through the development of the genetic and molecular profiling of tumors. The utilisation of information based on genetic diagnostics already offers cancer patients the opportunity to receive targeted treatment and avoid unnecessary treatment and … Continued
By Lotta Mitro
The study involved 62 patients who had been treated with 177Lu-PSMA-617 radiopharmaceuticals at Docrates between 2017 and 2019. The study showed that a 4-week treatment interval is safe for patients and leads to good outcomes. Nearly 60% of the patients in the study had a significant decrease in PSA of more than 50 percentage points. … Continued
By Lotta Mitro
Insured patients mean patients who finance their cancer diagnostics and treatment with private insurance under which the insurance compensates some of the patient’s costs. The policyholder and payer may be the patient or their employer. Commercial Director Jani Mikkola believes that the rapid growth in the number of insured patients at Docrates stems from, for … Continued
By Lotta Mitro
World Cancer Day takes place on February 4. According to the statistics of the Association of the Nordic Cancer Registries (NORDCAN), one in five people worldwide will develop cancer at some point in their lives, and about one in three in Finland. There are differences between men and women in terms of the onset of … Continued
By Lotta Mitro
Docrates’ services have taken huge steps since the year it was established. The hospital offered its first cancer treatments in October 2007. The aim of providing patients with state-of-the-art cancer therapies has guided the cancer center’s operations from the very beginning. In addition to cytostatic therapy, radiotherapy and surgical treatment, Docrates utilises modern and patient-specific … Continued
By Lotta Mitro
At the June 2022 American Society of Clinical Oncology (ASCO) conference, research findings on two new breast cancer drugs that not only prolong survival in patients with advanced breast cancer, but also alleviate symptoms and allow for more patients to be treated were presented. From the point of view of an ordinary person, cancer research … Continued
